2024
Sickle cell disease in India: the journey and hope for the future.
Gupta K, Krishnamurti L, Jain D. Sickle cell disease in India: the journey and hope for the future. Hematology 2024, 2024: 1-9. PMID: 39644008, PMCID: PMC11665512, DOI: 10.1182/hematology.2024000678.Peer-Reviewed Original ResearchConceptsSickle cell diseaseHematopoietic stem cell transplantationCell diseaseSeverity of sickle cell diseaseStem cell transplantationAcute chest syndromeVaso-occlusive crisisSurvive into adulthoodChest syndromePenicillin prophylaxisCell transplantationRenal involvementHydroxyurea therapyGene therapyClinical featuresNovel therapiesA-thalassemiaFetal HbNewborn screeningAvascular necrosisTranscranial DopplerComprehensive care programTherapyYounger ageFatal disease
2014
Prevalence of the βS Gene Among Scheduled Castes, Scheduled Tribes and Other Backward Class Groups in Central India
Shrikhande A, Arjunan A, Agarwal A, Dani A, Tijare J, Gettig E, Krishnamurti L. Prevalence of the βS Gene Among Scheduled Castes, Scheduled Tribes and Other Backward Class Groups in Central India. Hemoglobin 2014, 38: 230-235. PMID: 25023085, DOI: 10.3109/03630269.2014.931287.Peer-Reviewed Original ResearchConceptsSickle cell diseaseCommunity screeningCell diseaseVasoocclusive crisisComprehensive care programHigh-risk individualsSickle cell traitPneumococcal infectionDisease counselingWorld patientsUndiagnosed casesHigh prevalencePremature mortalityRisk individualsOrgan toxicityCare programEthnic groupsCell traitPrevalenceInherited disorderDistrict of NagpurDiseaseScheduled TribesPatientsScreening